[EN] HEPATITIS B ANTIVIRAL AGENTS<br/>[FR] AGENTS ANTIVIRAUX DE L'HÉPATITE B
申请人:NOVIRA THERAPEUTICS INC
公开号:WO2013096744A1
公开(公告)日:2013-06-27
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
[EN] NOVEL ANTIFUNGAL OXODIHYDROPYRIDINECARBOHYDRAZIDE DERIVATIVE<br/>[FR] NOUVEAU DÉRIVÉ OXODIHYDROPYRIDINECARBOHYDRAZIDE ANTIFONGIQUE
申请人:DAE WOONG PHARMA
公开号:WO2015060613A1
公开(公告)日:2015-04-30
The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.
Synthesis of <i>ortho</i>
-Azophenols by Formal Dehydrogenative Coupling of Phenols and Hydrazines or Hydrazides
作者:Kenneth Virgel N. Esguerra、Jean-Philip Lumb
DOI:10.1002/chem.201701226
日期:2017.6.27
synthesis, with applications as pigments and molecular switches. Herein, we describe a catalytic aerobic process that couples phenols and hydrazines or hydrazides for their synthesis. The key aromatic C-N bond is formed via condensation between the hydrazine or hydrazide and an ortho-quinone, which triggers a redox-isomerization to install the azo functionality. Notable features include rapid access to
[EN] 1,3-SUBSTITUED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACIC LEVELS<br/>[FR] COMPOSÉS PYRAZOLE 1,3-SUBSTITUÉS UTILES POUR LA RÉDUCTION DE NIVEAUX D'ACIDES GRAS À CHAÎNE TRÈS LONGUE
申请人:VERTEX PHARMA
公开号:WO2018107056A1
公开(公告)日:2018-06-14
Disclosed are chemical entities which are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein Formula (I) has the structure: R1a, R1b, R2, R3, R4a, R4b and Y are as defined herein. These chemical entities are useful for reduction of very long chain fatty acid levels. These chemical entities and pharmaceutically acceptable compositions comprising such chemical entities can be useful for treating various diseases, disorders and conditions, such as adrenoleukodystrophy (ALD).
Synthesis of 1,3,5-trisubstituted pyrazolines via Zn(ii)-catalyzed double hydroamination of enynes with aryl hydrazines
作者:Nitin T. Patil、Vipender Singh
DOI:10.1039/c1cc14850h
日期:——
An efficient Zn(II)-catalyzed intermolecular double hydroamination of 1,3-enynes with aryl hydrazines, for the synthesis of pyrazolines, has been discussed.